Found 11 matching trials
Study of Haplo-HSCT + Rivogenlecleucel vs Haplo-HSCT + Post Transplant Cyclophosphamide in Patients With AML or MDS
PHASE2This study compares the safety and effectiveness of giving rivogenlecleucel...
Location
TriStar Bone Marrow Transplant, LLC
Study of Matched Unrelated Donor T Cell Infusion for Hematologic Malignancies After Allo-HSCT
PHASE1This is a Phase I, multicenter, open-label, non-randomized study of matched...
Location
Multiple Locations
Long Term Follow-up Study for Patients Enrolled on the BP-004 Clinical Study
PHASE1This is a long-term follow up study evaluating the safety of BPX-501 T cell...
Location
IRCCS Ospedale Pediatrico Bambino Gesù
Safety Study of Gene Modified Donor T-cells Following TCRαβ+ Depleted Stem Cell Transplant
PHASE1This study will evaluate pediatric patients with malignant or non-malignant...
Location
IRCCS Ospedale Pediatrico Bambino Gesù
Safety Study of Gene Modified Donor T-cells Following Partially Mismatched Stem Cell Transplant
PHASE1This study will evaluate patients with blood cell cancers who are going to ...
Status
Active Not Recruiting
Location
Emory University Winship Cancer Institute
Study of Gene Modified Donor T-cells Following TCR Alpha Beta Positive Depleted Stem Cell Transplant
PHASE1This study will evaluate pediatric patients with malignant or non-malignant...
Status
Active Not Recruiting
Location
Children's Hospital Los Angeles
Safety Study of Gene Modified Donor T-Cells in Adults With Advanced Hematologic Malignancies
PHASE1This is an open-label, non-randomized study to evaluate the safety of two p...
Location
MD Anderson Cancer Center
BPX-501 T Cells Infused Post Stem Cell Transplant in Pediatrics With Non-Malignant Disorders Ineligible for BPU004 Study
N/AProviding access of BPX-501 gene modified T cells and rimiducid to pediatri...
Status
No Longer Available
Location
Children's Hospital Los Angeles
Safety Study of Gene Modified Donor T Cell Infusion After Stem Cell Transplant for Non-Malignant Diseases
PHASE1The purpose of this study is to determine a safe dose of BPX-501 gene modif...
Location
Fred Hutchinson Cancer ResearchCenter
Study of Gene Modified Donor T Cell Infusion in Patients With Recurrent Disease After Allogeneic Transplant
PHASE1A Phase I study of BPX-501 T cell infusion in adults with recurrent or mini...
Status
Active Not Recruiting
Location
BMT Program at Northside Hospital